Nxera Pharma Co Ownership
¥1,234.00
1.15%
Tokyo, Oct 05, 01:40 pm JST.
Closed.
ISIN
JP3431300007
Symbol
4565
Industry
Nxera Pharma Co Top Shareholders
| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
Gomi (Daisuke)
|
10.563m | 11.56% | +938.000k | Apr 23 2026 |
| 2 |
JIC Venture Growth Investments Co., Ltd.
|
5.610m | 6.14% | — | Dec 31 2025 |
| 3 |
Taiyo Pacific Partners LP
|
4.345m | 4.75% | -921.800k | Jun 18 2025 |
| 4 |
Great Fortune International Development Limited
|
3.053m | 3.34% | +3.053m | Dec 31 2025 |
| 5 |
Nomura Asset Management Co., Ltd.
|
2.666m | 2.92% | +24.400k | Mar 31 2026 |
|
1
Gomi (Daisuke)
|
11.56%
10.563m
|
|
2
JIC Venture Growth Investments Co., Ltd.
|
6.14%
5.610m
|
|
3
Taiyo Pacific Partners LP
|
4.75%
4.345m
|
|
4
Great Fortune International Development Limited
|
3.34%
3.053m
|
|
5
Nomura Asset Management Co., Ltd.
|
2.92%
2.666m
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 28.71% of Nxera Pharma Co, with Gomi (Daisuke) the biggest at 11.56%, followed by JIC Venture Growth Investments Co., Ltd. (6.14%) and Taiyo Pacific Partners LP (4.75%). |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
